SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1qs8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDT_B_MK1B902_1 (PROTEASE RETROPEPSIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 10	ASP A 316 ILE A 173 GLY A 172 GLY A 171 ILE A 149	None	0.93A	1sdtA-1qs8A: 6.3	1sdtA-1qs8A: 16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRL_D_TFPD207_1 (TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	LEU A 8 PHE A 156 LEU A 131 PHE A 154	None	0.99A	1wrlC-1qs8A: undetectable 1wrlD-1qs8A: undetectable	1wrlC-1qs8A: 13.99 1wrlD-1qs8A: 13.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DQY_C_CHDC3_0 (LIVER CARBOXYLESTERASE 1)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	LEU A 96 LYS A 148 LEU A 143 PRO A 99	None	1.19A	2dqyC-1qs8A: 0.0	2dqyC-1qs8A: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2G70_A_SAMA2001_1 (PHENYLETHANOLAMINE N-METHYLTRANSFERASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 7	TYR A 58 GLY A 23 ASP A 24 ASN A 25	None	1.07A	2g70A-1qs8A: undetectable	2g70A-1qs8A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2G70_B_SAMB2002_1 (PHENYLETHANOLAMINE N-METHYLTRANSFERASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 7	TYR A 58 GLY A 23 ASP A 24 ASN A 25	None	1.08A	2g70B-1qs8A: undetectable	2g70B-1qs8A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2G72_A_SAMA2001_1 (PHENYLETHANOLAMINE N-METHYLTRANSFERASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	TYR A 58 GLY A 23 ASP A 24 ASN A 25	None	1.04A	2g72A-1qs8A: undetectable	2g72A-1qs8A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2G72_B_SAMB2002_1 (PHENYLETHANOLAMINE N-METHYLTRANSFERASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 7	TYR A 58 GLY A 23 ASP A 24 ASN A 25	None	1.09A	2g72B-1qs8A: undetectable	2g72B-1qs8A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2O4N_A_TPVA300_2 (PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	LEU A 168 GLY A 122 ILE A 123 LEU A 8	None	0.76A	2o4nB-1qs8A: 6.0	2o4nB-1qs8A: 18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P02_A_SAMA2_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.14A	2p02A-1qs8A: undetectable	2p02A-1qs8A: 21.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2V0Z_C_C41C1328_1 (RENIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	7 / 12	ASP A 34 GLY A 36 SER A 37 TYR A 77 PHE A 120 ASP A 214 GLY A 216	None	0.63A	2v0zC-1qs8A: 41.6	2v0zC-1qs8A: 33.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2V0Z_O_C41O1327_1 (RENIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 12	ASP A 34 GLY A 36 PHE A 120 ASP A 214 GLY A 216	None	0.58A	2v0zO-1qs8A: 41.1	2v0zO-1qs8A: 33.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VL2_B_BEZB1162_0 (PEROXIREDOXIN-5)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 7	THR A 35 GLY A 127 LEU A 168 PHE A 156	None	1.03A	2vl2B-1qs8A: undetectable	2vl2B-1qs8A: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W98_B_P1ZB1358_1 (PROSTAGLANDIN REDUCTASE 2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	ASP A 214 TYR A 192 PHE A 305 LEU A 197	None	1.10A	2w98A-1qs8A: undetectable 2w98B-1qs8A: undetectable	2w98A-1qs8A: 24.41 2w98B-1qs8A: 24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BUF_A_AEGA394_0 (BETA-SECRETASE 1)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 5	ASP A 34 ILE A 114 ILE A 123 GLY A 216	None	0.68A	3bufA-1qs8A: 31.2	3bufA-1qs8A: 23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D4S_A_TIMA401_2 (BETA-2 ADRENERGIC RECEPTOR/T4-LYSOZYME CHIMERA)	1qs8	PLASMEPSIN (Plasmodium vivax)	3 / 3	THR A 92 SER A 97 PHE A 102	None	0.78A	3d4sA-1qs8A: undetectable	3d4sA-1qs8A: 21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 12	GLN A 204 LEU A 227 PHE A 231 MET A 274 MET A 289	None	1.45A	3h52C-1qs8A: undetectable	3h52C-1qs8A: 21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MDR_A_GJZA506_1 (CHOLESTEROL 24-HYDROXYLASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	LEU A 227 PHE A 231 ILE A 287 THR A 219	None	0.88A	3mdrA-1qs8A: 0.1	3mdrA-1qs8A: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PRS_A_RITA1001_2 (ENDOTHIAPEPSIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ASP A 34 GLY A 36 GLY A 78 ASP A 214 THR A 217 ILE A 300	None	0.40A	3prsA-1qs8A: 36.1	3prsA-1qs8A: 27.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 12	ASP A 34 GLY A 78 ILE A 212 THR A 217 ILE A 300	None	0.45A	3pwwA-1qs8A: 35.9	3pwwA-1qs8A: 27.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PWW_A_ROCA1001_2 (ENDOTHIAPEPSIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 8	GLY A 36 SER A 37 ILE A 75 TYR A 77 ASP A 214 THR A 218	None	0.54A	3pwwA-1qs8A: 35.9	3pwwA-1qs8A: 27.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	7 / 12	ILE A 32 ASP A 34 GLY A 36 GLY A 78 ASP A 214 THR A 217 ILE A 300	None	0.38A	3q70A-1qs8A: 12.0	3q70A-1qs8A: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 123 ASP A 34 GLY A 36 ASP A 214 THR A 217 ILE A 300	None	1.15A	3q70A-1qs8A: 12.0	3q70A-1qs8A: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 123 ASP A 34 ILE A 75 ASP A 214 THR A 217 ILE A 300	None	1.37A	3q70A-1qs8A: 12.0	3q70A-1qs8A: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 12	ILE A 212 ASP A 214 GLY A 216 GLY A 78 ASP A 34	None	0.70A	3q70A-1qs8A: 12.0	3q70A-1qs8A: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 212 ASP A 214 GLY A 216 ILE A 294 ASP A 34 ILE A 123	None	0.84A	3q70A-1qs8A: 12.0	3q70A-1qs8A: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q70_A_RITA2001_2 (CANDIDAPEPSIN-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	SER A 37 ILE A 75 TYR A 77 THR A 218	None	0.54A	3q70A-1qs8A: 12.0	3q70A-1qs8A: 30.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_A_RITA401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ASP A 34 GLY A 36 ILE A 75 GLY A 78 ASP A 214 ILE A 300	None	0.57A	3tneA-1qs8A: 34.9	3tneA-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_A_RITA401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 32 ASP A 34 GLY A 36 GLY A 78 ASP A 214 ILE A 300	None	0.42A	3tneA-1qs8A: 34.9	3tneA-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_A_RITA401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 123 ASP A 34 GLY A 36 GLY A 78 ASP A 214 ILE A 300	None	1.36A	3tneA-1qs8A: 34.9	3tneA-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_A_RITA401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 12	ILE A 212 ASP A 214 GLY A 216 ASP A 34 ILE A 123	None	0.69A	3tneA-1qs8A: 34.9	3tneA-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_A_RITA401_2 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	SER A 37 TYR A 77 THR A 217 THR A 218	None	0.36A	3tneA-1qs8A: 34.9	3tneA-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_B_RITB401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ASP A 34 GLY A 36 ILE A 75 GLY A 78 ASP A 214 ILE A 300	None	0.59A	3tneB-1qs8A: 35.0	3tneB-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_B_RITB401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 32 ASP A 34 GLY A 36 GLY A 78 ASP A 214 ILE A 300	None	0.42A	3tneB-1qs8A: 35.0	3tneB-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_B_RITB401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	ILE A 123 ASP A 34 GLY A 36 GLY A 78 ASP A 214 ILE A 300	None	1.32A	3tneB-1qs8A: 35.0	3tneB-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_B_RITB401_1 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 12	ILE A 212 ASP A 214 GLY A 216 ASP A 34 ILE A 123	None	0.71A	3tneB-1qs8A: 35.0	3tneB-1qs8A: 30.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TNE_B_RITB401_2 (SECRETED ASPARTIC PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	5 / 7	SER A 37 TYR A 77 ILE A 123 THR A 217 THR A 218	None	0.40A	3tneB-1qs8A: 35.0	3tneB-1qs8A: 30.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAQ_A_2GMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 6	TRP A 193 ILE A 195 VAL A 312 SER A 261	None	1.02A	4iaqA-1qs8A: undetectable	4iaqA-1qs8A: 21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KTT_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.18A	4kttA-1qs8A: undetectable	4kttA-1qs8A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KTT_C_SAMC404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.14A	4kttC-1qs8A: undetectable	4kttC-1qs8A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NDN_A_SAMA407_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.14A	4ndnA-1qs8A: undetectable	4ndnA-1qs8A: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLB_A_TRPA902_0 (PROTEIN ARGONAUTE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 5	LYS A 308 LEU A 268 GLU A 269 TYR A 272	None	1.46A	4olbA-1qs8A: undetectable	4olbA-1qs8A: 17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q5M_A_ROCA1101_3 (PROTEASE)	1qs8	PLASMEPSIN (Plasmodium vivax)	3 / 3	ASP A 214 ASP A 34 ASN A 39	None	0.53A	4q5mA-1qs8A: 9.9	4q5mA-1qs8A: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A1I_A_ADNA407_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.16A	5a1iA-1qs8A: undetectable	5a1iA-1qs8A: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECT_A_SAMA1300_0 (STIE PROTEIN)	1qs8	PLASMEPSIN (Plasmodium vivax)	6 / 12	LEU A 126 GLY A 127 ASP A 214 ILE A 136 LEU A 40 ILE A 103	None	1.26A	6ectA-1qs8A: undetectable	6ectA-1qs8A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FBN_B_SAMB401_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.15A	6fbnB-1qs8A: undetectable	6fbnB-1qs8A: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FBO_A_ADNA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.17A	6fboA-1qs8A: undetectable	6fboA-1qs8A: 14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FCB_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.14A	6fcbA-1qs8A: undetectable	6fcbA-1qs8A: 23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FCD_A_ADNA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	1qs8	PLASMEPSIN (Plasmodium vivax)	4 / 8	ASP A 107 SER A 50 SER A 116 ASP A 110	None	1.17A	6fcdA-1qs8A: undetectable	6fcdA-1qs8A: 14.11

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1SDT_B_MK1B902_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","1qs8","PLASMEPSIN","Plasmodium vivax",5,"ASP A 316;ILE A 173;GLY A 172;GLY A 171;ILE A 149","None","0.93A","1sdtA-1qs8A:6.3","1sdtA-1qs8A:16.41"],["1WRL_D_TFPD207_1","TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES","1qs8","PLASMEPSIN","Plasmodium vivax",4,"LEU A   8;PHE A 156;LEU A 131;PHE A 154","None","0.99A","1wrlC-1qs8A:undetectable;1wrlD-1qs8A:undetectable","1wrlC-1qs8A:13.99;1wrlD-1qs8A:13.99"],["2DQY_C_CHDC3_0","LIVER CARBOXYLESTERASE 1","1qs8","PLASMEPSIN","Plasmodium vivax",4,"LEU A  96;LYS A 148;LEU A 143;PRO A  99","None","1.19A","2dqyC-1qs8A:0.0","2dqyC-1qs8A:19.53"],["2G70_A_SAMA2001_1","PHENYLETHANOLAMINE N-METHYLTRANSFERASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"TYR A  58;GLY A  23;ASP A  24;ASN A  25","None","1.07A","2g70A-1qs8A:undetectable","2g70A-1qs8A:22.12"],["2G70_B_SAMB2002_1","PHENYLETHANOLAMINE N-METHYLTRANSFERASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"TYR A  58;GLY A  23;ASP A  24;ASN A  25","None","1.08A","2g70B-1qs8A:undetectable","2g70B-1qs8A:22.12"],["2G72_A_SAMA2001_1","PHENYLETHANOLAMINE N-METHYLTRANSFERASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"TYR A  58;GLY A  23;ASP A  24;ASN A  25","None","1.04A","2g72A-1qs8A:undetectable","2g72A-1qs8A:22.12"],["2G72_B_SAMB2002_1","PHENYLETHANOLAMINE N-METHYLTRANSFERASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"TYR A  58;GLY A  23;ASP A  24;ASN A  25","None","1.09A","2g72B-1qs8A:undetectable","2g72B-1qs8A:22.12"],["2O4N_A_TPVA300_2","PROTEASE;PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"LEU A 168;GLY A 122;ILE A 123;LEU A   8","None","0.76A","2o4nB-1qs8A:6.0","2o4nB-1qs8A:18.01"],["2P02_A_SAMA2_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.14A","2p02A-1qs8A:undetectable","2p02A-1qs8A:21.83"],["2V0Z_C_C41C1328_1","RENIN","1qs8","PLASMEPSIN","Plasmodium vivax",7,"ASP A  34;GLY A  36;SER A  37;TYR A  77;PHE A 120;ASP A 214;GLY A 216","None","0.63A","2v0zC-1qs8A:41.6","2v0zC-1qs8A:33.43"],["2V0Z_O_C41O1327_1","RENIN","1qs8","PLASMEPSIN","Plasmodium vivax",5,"ASP A  34;GLY A  36;PHE A 120;ASP A 214;GLY A 216","None","0.58A","2v0zO-1qs8A:41.1","2v0zO-1qs8A:33.43"],["2VL2_B_BEZB1162_0","PEROXIREDOXIN-5","1qs8","PLASMEPSIN","Plasmodium vivax",4,"THR A  35;GLY A 127;LEU A 168;PHE A 156","None","1.03A","2vl2B-1qs8A:undetectable","2vl2B-1qs8A:18.98"],["2W98_B_P1ZB1358_1","PROSTAGLANDIN REDUCTASE 2;PROSTAGLANDIN REDUCTASE 2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 214;TYR A 192;PHE A 305;LEU A 197","None","1.10A","2w98A-1qs8A:undetectable;2w98B-1qs8A:undetectable","2w98A-1qs8A:24.41;2w98B-1qs8A:24.41"],["3BUF_A_AEGA394_0","BETA-SECRETASE 1","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A  34;ILE A 114;ILE A 123;GLY A 216","None","0.68A","3bufA-1qs8A:31.2","3bufA-1qs8A:23.28"],["3D4S_A_TIMA401_2","BETA-2 ADRENERGIC RECEPTOR\/T4-LYSOZYME CHIMERA","1qs8","PLASMEPSIN","Plasmodium vivax",3,"THR A  92;SER A  97;PHE A 102","None","0.78A","3d4sA-1qs8A:undetectable","3d4sA-1qs8A:21.06"],["3H52_C_486C4_1","GLUCOCORTICOID RECEPTOR","1qs8","PLASMEPSIN","Plasmodium vivax",5,"GLN A 204;LEU A 227;PHE A 231;MET A 274;MET A 289","None","1.45A","3h52C-1qs8A:undetectable","3h52C-1qs8A:21.05"],["3MDR_A_GJZA506_1","CHOLESTEROL 24-HYDROXYLASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"LEU A 227;PHE A 231;ILE A 287;THR A 219","None","0.88A","3mdrA-1qs8A:0.1","3mdrA-1qs8A:23.08"],["3PRS_A_RITA1001_2","ENDOTHIAPEPSIN","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ASP A  34;GLY A  36;GLY A  78;ASP A 214;THR A 217;ILE A 300","None","0.40A","3prsA-1qs8A:36.1","3prsA-1qs8A:27.01"],["3PWW_A_ROCA1001_1","ENDOTHIAPEPSIN","1qs8","PLASMEPSIN","Plasmodium vivax",5,"ASP A  34;GLY A  78;ILE A 212;THR A 217;ILE A 300","None","0.45A","3pwwA-1qs8A:35.9","3pwwA-1qs8A:27.01"],["3PWW_A_ROCA1001_2","ENDOTHIAPEPSIN","1qs8","PLASMEPSIN","Plasmodium vivax",6,"GLY A  36;SER A  37;ILE A  75;TYR A  77;ASP A 214;THR A 218","None","0.54A","3pwwA-1qs8A:35.9","3pwwA-1qs8A:27.01"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","1qs8","PLASMEPSIN","Plasmodium vivax",7,"ILE A  32;ASP A  34;GLY A  36;GLY A  78;ASP A 214;THR A 217;ILE A 300","None","0.38A","3q70A-1qs8A:12.0","3q70A-1qs8A:30.08"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A 123;ASP A  34;GLY A  36;ASP A 214;THR A 217;ILE A 300","None","1.15A","3q70A-1qs8A:12.0","3q70A-1qs8A:30.08"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A 123;ASP A  34;ILE A  75;ASP A 214;THR A 217;ILE A 300","None","1.37A","3q70A-1qs8A:12.0","3q70A-1qs8A:30.08"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","1qs8","PLASMEPSIN","Plasmodium vivax",5,"ILE A 212;ASP A 214;GLY A 216;GLY A  78;ASP A  34","None","0.70A","3q70A-1qs8A:12.0","3q70A-1qs8A:30.08"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A 212;ASP A 214;GLY A 216;ILE A 294;ASP A  34;ILE A 123","None","0.84A","3q70A-1qs8A:12.0","3q70A-1qs8A:30.08"],["3Q70_A_RITA2001_2","CANDIDAPEPSIN-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"SER A  37;ILE A  75;TYR A  77;THR A 218","None","0.54A","3q70A-1qs8A:12.0","3q70A-1qs8A:30.08"],["3TNE_A_RITA401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ASP A  34;GLY A  36;ILE A  75;GLY A  78;ASP A 214;ILE A 300","None","0.57A","3tneA-1qs8A:34.9","3tneA-1qs8A:30.03"],["3TNE_A_RITA401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A  32;ASP A  34;GLY A  36;GLY A  78;ASP A 214;ILE A 300","None","0.42A","3tneA-1qs8A:34.9","3tneA-1qs8A:30.03"],["3TNE_A_RITA401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A 123;ASP A  34;GLY A  36;GLY A  78;ASP A 214;ILE A 300","None","1.36A","3tneA-1qs8A:34.9","3tneA-1qs8A:30.03"],["3TNE_A_RITA401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",5,"ILE A 212;ASP A 214;GLY A 216;ASP A  34;ILE A 123","None","0.69A","3tneA-1qs8A:34.9","3tneA-1qs8A:30.03"],["3TNE_A_RITA401_2","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",4,"SER A  37;TYR A  77;THR A 217;THR A 218","None","0.36A","3tneA-1qs8A:34.9","3tneA-1qs8A:30.03"],["3TNE_B_RITB401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ASP A  34;GLY A  36;ILE A  75;GLY A  78;ASP A 214;ILE A 300","None","0.59A","3tneB-1qs8A:35.0","3tneB-1qs8A:30.03"],["3TNE_B_RITB401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A  32;ASP A  34;GLY A  36;GLY A  78;ASP A 214;ILE A 300","None","0.42A","3tneB-1qs8A:35.0","3tneB-1qs8A:30.03"],["3TNE_B_RITB401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",6,"ILE A 123;ASP A  34;GLY A  36;GLY A  78;ASP A 214;ILE A 300","None","1.32A","3tneB-1qs8A:35.0","3tneB-1qs8A:30.03"],["3TNE_B_RITB401_1","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",5,"ILE A 212;ASP A 214;GLY A 216;ASP A  34;ILE A 123","None","0.71A","3tneB-1qs8A:35.0","3tneB-1qs8A:30.03"],["3TNE_B_RITB401_2","SECRETED ASPARTIC PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",5,"SER A  37;TYR A  77;ILE A 123;THR A 217;THR A 218","None","0.40A","3tneB-1qs8A:35.0","3tneB-1qs8A:30.03"],["4IAQ_A_2GMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","1qs8","PLASMEPSIN","Plasmodium vivax",4,"TRP A 193;ILE A 195;VAL A 312;SER A 261","None","1.02A","4iaqA-1qs8A:undetectable","4iaqA-1qs8A:21.65"],["4KTT_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.18A","4kttA-1qs8A:undetectable","4kttA-1qs8A:21.83"],["4KTT_C_SAMC404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.14A","4kttC-1qs8A:undetectable","4kttC-1qs8A:21.83"],["4NDN_A_SAMA407_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.14A","4ndnA-1qs8A:undetectable","4ndnA-1qs8A:21.91"],["4OLB_A_TRPA902_0","PROTEIN ARGONAUTE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"LYS A 308;LEU A 268;GLU A 269;TYR A 272","None","1.46A","4olbA-1qs8A:undetectable","4olbA-1qs8A:17.06"],["4Q5M_A_ROCA1101_3","PROTEASE","1qs8","PLASMEPSIN","Plasmodium vivax",3,"ASP A 214;ASP A  34;ASN A  39","None","0.53A","4q5mA-1qs8A:9.9","4q5mA-1qs8A:22.78"],["5A1I_A_ADNA407_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.16A","5a1iA-1qs8A:undetectable","5a1iA-1qs8A:21.91"],["6ECT_A_SAMA1300_0","STIE PROTEIN","1qs8","PLASMEPSIN","Plasmodium vivax",6,"LEU A 126;GLY A 127;ASP A 214;ILE A 136;LEU A  40;ILE A 103","None","1.26A","6ectA-1qs8A:undetectable","6ectA-1qs8A:21.89"],["6FBN_B_SAMB401_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.15A","6fbnB-1qs8A:undetectable","6fbnB-1qs8A:21.91"],["6FBO_A_ADNA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.17A","6fboA-1qs8A:undetectable","6fboA-1qs8A:14.11"],["6FCB_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.14A","6fcbA-1qs8A:undetectable","6fcbA-1qs8A:23.00"],["6FCD_A_ADNA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","1qs8","PLASMEPSIN","Plasmodium vivax",4,"ASP A 107;SER A  50;SER A 116;ASP A 110","None","1.17A","6fcdA-1qs8A:undetectable","6fcdA-1qs8A:14.11"]]